Study Stopped
On April 15, 2019, BIOTRONIK received FDA approval to transition the ongoing Protego DF4 Post Approval Registry to a new EP PASSION real-world data methodology.
Protego DF4 Post Approval Registry
1 other identifier
observational
1,694
1 country
68
Brief Summary
The purpose of this registry study is to confirm the long-term safety and reliability of the Protego DF4 right ventricular lead.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2014
Longer than P75 for all trials
68 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 11, 2014
CompletedFirst Posted
Study publicly available on registry
September 18, 2014
CompletedStudy Start
First participant enrolled
September 27, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 17, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
April 17, 2019
CompletedResults Posted
Study results publicly available
April 22, 2020
CompletedJune 22, 2020
June 1, 2020
4.6 years
September 11, 2014
April 8, 2020
June 8, 2020
Conditions
Outcome Measures
Primary Outcomes (2)
Percentage of Subjects With No Protego DF4 Lead Adverse Event
Evaluate the percentage of subjects without an adverse event related to the Protego DF4 lead or header through 5 years. The endpoint is analyzed as the adverse event free-rate.
Up to 4.5 years
Protego DF4 Lead Safety-Individual Adverse Event-Free Rate
Evaluate the individual types of adverse events contributing to primary outcome measure 'Protego DF4 Lead Safety-Overall Adverse Event-Free Rate'.
Up to 4.5 years
Secondary Outcomes (5)
Protego DF4 Lead Pacing Threshold Measurement
Up to 4.5 years
Protego DF4 Lead Shock Impedance
Up to 4.5 years
Percentage of Subjects With no Adverse Events Excluded From Primary Objectives
Up to 4.5 years
Protego DF4 Lead Sensing
Up to 4.5 years
Protego DF4 Lead Pacing Impedance
Up to 4.5 years
Eligibility Criteria
The patients selected for participation should be from the investigators' general patient population according to the inclusion and exclusion criteria.
You may qualify if:
- Implanted within the last 30 days or candidate for implantation of a BIOTRONIK ICD or CRT-D DF4 compatible system along with the Protego DF4 lead
- Meets ICD or CRT-D system implant recommendations as defined in guidelines published by relevant professional societies
- Able to understand the nature of the registry and provide informed consent
- Available for follow-up visits on a regular basis at the investigational site for the expected 5 years of follow-up
- Age greater than or equal to 18 years
You may not qualify if:
- Enrolled in any investigational cardiac device trial
- Planned cardiac surgical procedures or interventional measures within the next 6 months
- Expected to receive heart transplantation or ventricular assist device within 1 year
- Life expectancy of less than 1 year
- Presence of another life-threatening, underlying illness separate from their cardiac disorder
- Patients reporting pregnancy at the time of enrollment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Biotronik, Inc.lead
Study Sites (68)
Unknown Facility
Gadsden, Alabama, United States
Unknown Facility
Avondale, Arizona, United States
Unknown Facility
Glendale, Arizona, United States
Unknown Facility
Peoria, Arizona, United States
Unknown Facility
Phoenix, Arizona, United States
Unknown Facility
Escondido, California, United States
Unknown Facility
Fountain Valley, California, United States
Unknown Facility
Hawthorne, California, United States
Unknown Facility
Los Angeles, California, United States
Unknown Facility
Santa Barbara, California, United States
Unknown Facility
Temecula, California, United States
Unknown Facility
Torrance, California, United States
Unknown Facility
Norwalk, Connecticut, United States
Unknown Facility
Brooksville, Florida, United States
Unknown Facility
Daytona Beach, Florida, United States
Unknown Facility
Kissimmee, Florida, United States
Unknown Facility
Miami, Florida, United States
Unknown Facility
New Smyrna Beach, Florida, United States
Unknown Facility
Orlando, Florida, United States
Unknown Facility
St. Petersburg, Florida, United States
Unknown Facility
Winter Park, Florida, United States
Unknown Facility
Zephyrhills, Florida, United States
Unknown Facility
Alton, Illinois, United States
Unknown Facility
Aurora, Illinois, United States
Unknown Facility
Chicago, Illinois, United States
Unknown Facility
Schaumburg, Illinois, United States
Unknown Facility
Fort Wayne, Indiana, United States
Unknown Facility
Lexington, Kentucky, United States
Unknown Facility
Owensboro, Kentucky, United States
Unknown Facility
Lafayette, Louisiana, United States
Unknown Facility
Lake Charles, Louisiana, United States
Unknown Facility
Bangor, Maine, United States
Unknown Facility
Baltimore, Maryland, United States
Unknown Facility
Cumberland, Maryland, United States
Unknown Facility
Worcester, Massachusetts, United States
Unknown Facility
Detroit, Michigan, United States
Unknown Facility
Flint, Michigan, United States
Unknown Facility
Lansing, Michigan, United States
Unknown Facility
Rochester Hills, Michigan, United States
Unknown Facility
Wyoming, Michigan, United States
Unknown Facility
Ypsilanti, Michigan, United States
Unknown Facility
St Louis, Missouri, United States
Unknown Facility
Clifton, New Jersey, United States
Unknown Facility
Mineola, New York, United States
Unknown Facility
Stony Brook, New York, United States
Unknown Facility
Winston-Salem, North Carolina, United States
Unknown Facility
Fargo, North Dakota, United States
Unknown Facility
Cincinnati, Ohio, United States
Unknown Facility
Middletown, Ohio, United States
Unknown Facility
Steubenville, Ohio, United States
Unknown Facility
Philadelphia, Pennsylvania, United States
Unknown Facility
Anderson, South Carolina, United States
Unknown Facility
Columbia, South Carolina, United States
Unknown Facility
Greenville, South Carolina, United States
Unknown Facility
Lancaster, South Carolina, United States
Unknown Facility
Mt. Pleasant, South Carolina, United States
Unknown Facility
Rock Hill, South Carolina, United States
Unknown Facility
Corpus Christi, Texas, United States
Unknown Facility
Fort Worth, Texas, United States
Unknown Facility
Houston, Texas, United States
Unknown Facility
Kingwood, Texas, United States
Unknown Facility
San Antonio, Texas, United States
Unknown Facility
Tomball, Texas, United States
Unknown Facility
Burlington, Vermont, United States
Unknown Facility
Chesapeake, Virginia, United States
Unknown Facility
Fredericksburg, Virginia, United States
Unknown Facility
Norfolk, Virginia, United States
Unknown Facility
Seattle, Washington, United States
Results Point of Contact
- Title
- Clinical Studies Engineer Manager
- Organization
- BIOTRONIK, Inc.
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- Yes
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Target Duration
- 5 Years
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 11, 2014
First Posted
September 18, 2014
Study Start
September 27, 2014
Primary Completion
April 17, 2019
Study Completion
April 17, 2019
Last Updated
June 22, 2020
Results First Posted
April 22, 2020
Record last verified: 2020-06